European Medicine’s Agency – Reflection paper on the use of artificial intelligence in the lifecycle of medicines
Date: September 25, 2023
The EMA has opened a public consultation on a reflection paper presenting views on artificial intelligence and machine learning at any step of the lifecycle of human and veterinary medicines, from drug discovery to the post-authorisation setting.
All interested stakeholders are invited to comment on the draft reflection paper and to identify opportunities and risks of AI in the field of medicines – deadline: 31 December 2023
The topic will be further discussed during a joint HMA/EMA workshop scheduled for 20-21 November 2023.
The feedback from stakeholders will be analysed and considered for the finalisation of the reflection paper and future development of guidance as relevant.
Find out more here.
